Research To Help Patients Make Informed Decisions About Breast MRI
(June 22, 2023) — While many people think that breast cancer screening and mammography are synonymous, Claire Conley, PhD, wants people to know that women who are at higher than average risk for breast cancer may also receive a breast MRI.

However, few of those who are eligible take advantage of the opportunity to get a breast MRI, which can detect smaller tumors earlier and increase the odds that they can be effectively treated. “Not many people choose to get an MRI, and that number is lower when we think about people of color,” said Conley, an assistant professor of oncology at Georgetown University’s Lombardi Comprehensive Cancer Center.
It’s unclear why Black and Hispanic women are less likely to get a breast MRI. The potentially high insurance co-pay and the out-of-pocket costs are only part of the story. Health care disparities can certainly play a role. Conley says a lack of information sharing and thus awareness is certainly a possibility. “A lot of people I’ve talked to say that they’ve never even heard of a breast MRI before,” Conley said.
As a researcher, Conley is exploring the reasons why and developing a tool to help patients make an informed decision on the subject. In April, she received a K08 career development award from the National Cancer Institute to support her research.
“I just want people to know that it’s an option, and if they’re choosing not to pursue it, that they’re making an informed decision about it, as opposed to people not even being presented with the option,” Conley said.
Psychology Major to Survivorship Researcher
When Conley was in high school, her mother was diagnosed with breast cancer. “I saw firsthand how cancer can affect individuals and families as people are going through the treatment process and adjusting back to life after cancer,” she said.

Conley’s mother would later take credit for her daughter’s career path. While Conley majored in psychology at the University of Notre Dame, her mother participated in a study on cancer survivors and exercise. After learning that many of those working on cancer research were psychologists, Conley’s mother connected her with researchers studying ways to treat people facing depression and fatigue after receiving a cancer diagnosis.
With her background in psychology, Conley studies how people feel along the spectrum of cancer survivorship from diagnosis to end-of-life issues.
“Some people give me weird looks when I say I’m a clinical psychologist and I work in oncology,” she said. “For me, it comes from a very personal place, but also, people recognize that behavior impacts cancer prevention, screening and treatment. So that’s a key area for us to improve outcomes related to cancer.”
The FYI on Breast MRI
There are a number of reasons someone might have higher than average risk of developing breast cancer, including having a family history of breast cancer, genetic factors or benign non-cancerous breast diseases.

Based on her family history of breast and ovarian cancer, Melanie A. Nix and her OB/GYN decided she should undergo genetic testing, which revealed that she had the BRCA1 gene. “When we learned of my BRCA1 genetic mutation, my OB/GYN suggested that more aggressive screening, MRI, would be appropriate,” said Nix, chair of the community advisory council for Georgetown’s Office of Minority Health & Health Disparities Research. “We also started consulting on preventive surgeries.”
Breast MRI can detect smaller cancers, but it takes more time than a mammogram and can be difficult for patients who experience claustrophobia. It can also be expensive.
“Even if breast MRI is covered by health insurance, for those with high-deductible insurance plans, you might have a high copay,” Conley said. “So it’s more financially burdensome than a mammogram.”
Initially, Nix’s insurance company refused to cover a breast MRI, a decision they later reversed after her doctor explained that she was at high risk. In November 2008, a breast MRI showed that Nix had breast cancer, which was confirmed with a biopsy.
“After my biopsy, I had a mammogram and my breast cancer was undetectable at that time,” Nix said. “I was diagnosed with triple-negative breast cancer that tends to be a more aggressive breast cancer subtype.
“I do credit MRI and early detection with my survival,” Nix added.
Making An Informed Decision
Ultimately, patients’ breast cancer screening needs will vary based on their risk factors. “If you’re applying the same guidelines for everyone, they might not fit everyone,” Conley said.
Black women are more often diagnosed with breast cancer at younger ages and with more aggressive types of cancer than their white counterparts, making it important for them to talk to their doctors about breast MRI, Nix said.
“Everyone has unique circumstances that may make it more beneficial or not for them to get an MRI,” she said. “Because this is such an important and potentially lifesaving decision, I would encourage women to have in-depth conversations with their medical professionals, understand their medical and family history, and fully research the pros and cons to make an informed decision.”
Kat Zambon
GUMC Communications
-
Research To Help Patients Make Informed Decisions About Breast MRI
While many people think that breast cancer screening and mammography are synonymous, Claire Conley, PhD, wants people to know that women who are at higher than average risk for breast cancer may also receive a breast MRI.
Category: Lombardi Stories
-
Researchers Develop Method to Monitor Cancer Radiotherapy Effects at the Cellular Level
Using complex molecular tools, researchers have determined how to measure, in real time, the effect that radiation treatment for cancer can have at the cellular level on surrounding healthy tissue.
Category: News Release
-
Novel Research Shows Older Breast Cancer Survivors Experience Accelerated Aging, Worse Functional Outcomes
In a new multicenter study, researchers from Georgetown University’s Lombardi Comprehensive Cancer Center, the Medical College of Wisconsin (MCW), UCLA and several other leading cancer centers from across the nation examined whether cancer and its treatments accelerate aging. Using novel epigenetic measures to assess biological aging, investigators found that older breast cancer survivors — particularly those exposed to chemotherapy — showed greater epigenetic aging than their same-aged peers without cancer, which may relate to worse outcomes.
Category: News Release
-
Determining How a Sugar Molecule Can Affect Cancer Cell Response to Chemoradiotherapy
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues who have been exploring the complexities of biochemical pathways involved in cancer development have found that a form of glucose, a type of sugar, is intricately linked to a pathway used to build DNA molecules. When this pathway is overactive, it can lead to cancer and resistance to chemoradiotherapy.
Category: News Release
-
Veterans Exposed to Agent Orange May Be at Increased Risk of Developing Progressive Blood Cancers
Research conducted at Georgetown University’s Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins.
Category: News Release
-
Types of Bacteria Vary Widely in Tumors of People with Early vs. Late-Onset Colorectal Cancer
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center studied the microbiome of people with colorectal cancer and found the makeup of the bacteria, fungi and viruses in a person’s tumor varied significantly depending on whether they were diagnosed with early onset disease (age 45 or younger) or late-onset disease (age 65 or older).
Category: News Release
-
Lombardi Gala Celebrates Hope
Friends and supporters gathered for the 35th annual Lombardi Gala to celebrate life and hope in the face of cancer and rally support for funding cancer research at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: Lombardi Stories
-
Georgetown Lombardi Young Scholars Gain Hands-On Science Experience
A team of eager third graders from Van Ness Elementary in southeast Washington, D.C., recently teamed up with volunteers from Georgetown University’s Lombardi Comprehensive Cancer Center for hands-on experiences with robotics, programming, biology and engineering designed to encourage students to think about careers in science and medicine.
Category: Lombardi Stories
-
New Study Finds Personalized mRNA Vaccine Given with Immunotherapy Reduces Recurrence in High-Risk Melanoma Patients
A new study conducted by an international team of researchers, including clinical investigators at Georgetown University’s Lombardi Comprehensive Cancer Center, demonstrates that a personalized cancer mRNA vaccine combined with immunotherapy reduces recurrence and improves survival for people with advanced melanoma.
Category: Lombardi Stories
-
Ralph Lauren Center for Cancer Prevention — Part of Washington’s Fabric
Lombardi Comprehensive Cancer Center’s newly dedicated Ralph Lauren Center for Cancer Prevention, with its quadrupling of health-focused staff, brings renewed hope that those who have been historically underserved in the Washington, DC, area will now have access to more cancer-related services and the potential of turning the tide on the high rate of cancer in the city.
Category: Lombardi Stories